Utilization of internet-based survivorship care plans by lung cancer survivors

Clinical Lung Cancer

Volumn 10, Issue 5, 2009, Pages 347-352

  Hill Kayser, Christine E ^a   Vachani, Carolyn ^a   Hampshire, Margaret K ^a   Jacobs, Linda A ^b   Metz, James M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Comorbidities; Long term cancer survivors; OncoLife; OncoLink; Survivorship care plan; Web

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVOR; COMORBIDITY; FEMALE; FOLLOW UP; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INTERNET; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE;

EID: 77249131809     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2009.n.047     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58:71-96.
2. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004; 101:3-27.
3. Ko CY, Maggard M, Livingston EH. Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nationwide, populationbased assessment. J Surg Res 2003; 114:1-5.
4. Thomas PA Jr, Rubinstein L. Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer. The Lung Cancer Study Group. J Thorac Cardiovasc Surg 1993; 106:1053-1058
5. Tucker MA, Murray N, Shaw EG, et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst 1997; 89:1782-1788
6. Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer 2004; 101:1712-1719
7. Stanton AL. Psychosocial concerns and interventions for cancer survivors. J Clin Oncol 2006; 24:5132-5137
8. Snyder CF, Earle CC, Herbert RJ, et al. Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol 2008; 26:1073-1079
9. Hewitt M, Greenfield S, Stoval E. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Academies Press; 2005.
10. Fisher RA. On the interpretation of ?2 from contingency tables, and the calculation of P. J R Stat Soc 1922; 85:87-94.
11. Gossett WS. The probable error of a mean. Biometrika 1908; 6:1-25.
12. Centers for Disease Control and Prevention (CDC). Cancer Survivorship United States, 1971 - 2001. MMWR Morb Mortal Wkly Rep 2004; 53:526-529
13. National Coalition for Cancer Survivorship [Web site]. Available at: http://www. canceradvocacy.org/about/org/history/html. Accessed: January 10, 2009.
14. Visbal AL, Williams BA, Nichols FC III, et al. Gender differences in non-smallcell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 2004; 78:209-215, discussion 15.
15. National Cancer Institute [Web site]. SEER Cancer Statistics Review, 1973-1999. Available at: http://seer.cancer.gov/csr/1973-1999/. Accessed: September 1, 2009.
16. van de Poll-Franse LV, van Eenbergen MC. Internet use by cancer survivors: current use and future wishes. Support Care Cancer 2008; 16:1189-1195
17. Metz JM, Devine P, DeNittis A, et al. A multi-institutional study of Internet utilization by radiation oncology patients. Int J Radiat Oncol Biol Phys 2003; 56:1201-1205
18. Wilson JJ, Mick R, Wei SJ, et al. Clinical trial resources on the internet must be designed to reach underrepresented minorities. Cancer J 2006; 12:475-481
19. Fu JB, Kau TY, Severson RK, et al. Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest 2005; 127:768-777
20. International Early Lung Cancer Action Program Investigators, Henschke CI, Yip R, et al. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer [erratum appears in: JAMA 2008; 299:1775].
21. Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004; 22:330-353
22. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350:351-360
23. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005; 352:2589-2597 (Pubitemid 41007845)
24. Sause WT, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995; 87:198-205.
25. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992; 326:524-530
26. Komaki R, Scott CB, Sause WT, et al. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 1997; 39:537-544
27. Bonner JA. The role of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma: seeking to optimize local control and survival while minimizing toxicity. Cancer 1999; 86:195-196
28. Blanco JA, Toste IS, Alvarez RF, et al. Age, comorbidity, treatment decision and prognosis in lung cancer. Age Ageing 2008; 37:715-718
29. International Early Lung Cancer Action Program Investigators, Henschke CI, Yip R, et al. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer [erratum appears in: JAMA 2006; 296:180-184